Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.1K
Overview
83.1K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.7K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.6K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K
T Cell Types and Functions01:24

T Cell Types and Functions

2.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Allergic Reactions02:06

Allergic Reactions

31.8K
Overview
31.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of CO<sub>2</sub> tolerance genes associated with virulence in the fungal pathogen Cryptococcus neoformans.

Nature microbiology·2024
Same author

Cryptococcus neoformans adapts to the host environment through TOR-mediated remodeling of phospholipid asymmetry.

Nature communications·2023
Same author

RfaH Counter-Silences Inhibition of Transcript Elongation by H-NS-StpA Nucleoprotein Filaments in Pathogenic Escherichia coli.

mBio·2022
Same author

The granuloma in cryptococcal disease.

PLoS pathogens·2021
Same author

Tailoring a Global Iron Regulon to a Uropathogen.

mBio·2020
Same author

Complex Multilevel Control of Hemolysin Production by Uropathogenic Escherichia coli.

mBio·2019
Same journal

Chemical, Biological, and Ecological Evidence for Aerobic Deoxynivalenol Detoxification in Agronomic Soil-Derived Bacterial Communities.

Toxins·2026
Same journal

Botulinum Toxin Treatment for Uncommon Phenotypes of Laryngeal Adductor Breathing Dystonia.

Toxins·2026
Same journal

Enhancing Neuronal Networks with <i>Rhinella schneideri</i> Skin Secretion Molecules: Implications for Neurodegenerative Disorders.

Toxins·2026
Same journal

Dangerous Measures: A Case Report and Review of Motoro Ray Envenomation.

Toxins·2026
Same journal

The Impact of OnabotulinumtoxinA on Oral Pain Medication Prescription Fills and Low-Value Care in Patients with Cervical Dystonia in the United States: A Retrospective Claims Analysis.

Toxins·2026
Same journal

Broad-Spectrum Antiviral and Antibacterial Activity of the Scorpion Venom Peptide HP1090.

Toxins·2026
See all related articles

Related Experiment Video

Updated: Jan 1, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.9K

RTX Toxins Ambush Immunity's First Cellular Responders.

Laura C Ristow1, Rodney A Welch1

  • 1Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI 53706, USA.

Toxins
|December 15, 2019
PubMed
Summary
This summary is machine-generated.

Repeats-in-toxin (RTX) toxins target leukocytes by binding to β2 integrins. Understanding these interactions is key to developing new therapies against bacterial infections.

Keywords:
Gram-negative bacteriaRTX (repeats-in-toxin) toxin familyvirulence factorβ2 integrins

More Related Videos

Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy
14:29

Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy

Published on: October 1, 2012

12.4K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.9K

Related Experiment Videos

Last Updated: Jan 1, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.9K
Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy
14:29

Visualization of Bacterial Toxin Induced Responses Using Live Cell Fluorescence Microscopy

Published on: October 1, 2012

12.4K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.9K

Area of Science:

  • Bacterial Pathogenesis
  • Immunology
  • Molecular Biology

Background:

  • Repeats-in-toxin (RTX) proteins are bacterial exoproteins with diverse functions, including toxins.
  • RTX toxins are secreted by Gram-negative pathogens and play a role in virulence.
  • Leukocytes express β2 integrins, which are crucial for immune responses.

Purpose of the Study:

  • To review well-characterized RTX toxins and their interactions with the β2 integrin receptor.
  • To summarize research on the specific domains of RTX toxins and β2 integrins involved in cytotoxicity.
  • To explore the potential for therapeutic targeting of the RTX-β2 integrin interaction.

Main Methods:

  • Literature review of studies on RTX toxins (LtxA, LktA, CyaA, HlyA, ApxIIIA) and β2 integrins.
  • Analysis of research detailing RTX toxin domains responsible for cytotoxic and hemolytic activity.
  • Examination of studies identifying specific β2 integrin domains critical for RTX toxin interaction.

Main Results:

  • RTX toxins, including LtxA, LktA, HlyA, and ApxIIIA, target the common β2 integrin subunit found on leukocytes.
  • Specific domains within both RTX toxins and β2 integrins are essential for mediating cytotoxic effects.
  • This targeted interaction provides a significant advantage to bacterial pathogens by neutralizing host immune cells.

Conclusions:

  • RTX toxins exhibit a conserved mechanism of action by targeting the β2 integrin receptor on leukocytes.
  • The specificity of the RTX-β2 integrin interaction presents a potential target for therapeutic intervention.
  • Further research is needed to determine if this interaction can be effectively modulated for therapeutic benefit.